Dr Albert Bourla, Chairman And Chief Executive Officer, Pfizer Inc, Chairman And Chief Executive Officer, Pfizer Inc
Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California. As of October five, 2022, Global Blood Therapeutics, Inc. operates as a subsidiary of Pfizer Inc.. Global Blood Therapeutics, Inc. announced positive final results from true-globe and lengthy-term research with Oxbryta® tablets for the treatment of sickle cell illness . A initially-in-class oral, once-everyday therapy, Oxbryta straight inhibits sickle hemoglobin polymerization, the root cause of the sickling and destruction of red blood cells in SCD. Final results from a huge retrospective analysis of three,128 SCD sufferers treated with Oxbryta showed a statistically considerable improvement...